Market Research Logo

Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review

Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Benitec Biopharma Limited (Benitec), is a research based clinical stage biotechnology company. The company develops novel therapeutics for the treatment of chronic and life threatening diseases based on its proprietary gene silencing DNA directed RNA interference (ddRNAi) technology. It develops g ddRNAi based therapeutics for various conditions such as hepatitis B, wet age related macular degeneration and OPMD. The company also licenses its ddRNAi to various biopharmaceutical companies for the development of drugs for the treatment of conditions such as HIV/AIDS, Huntington's disease, chronic neuropathic pain, cancer immunotherapy and retinitis. The company has its research laboratories in Hayward, California, the US. Benitec is headquartered in Sydney, New South Wales, Australia.

Benitec Biopharma Limited Key Recent Developments

Aug 16, 2016: Benitec Announces Appointment Of New Director And Chair Of Audit Committee And Retirement Of Director, Mr Iain Ross
Aug 10, 2016: Benitec announces restructuring of Senior Executive team
Jun 16, 2016: Benite Biopharma: Federal R&D Tax Credit Received
May 24, 2016: Benitec Biopharma Interim Report for the Nine Months Ended March 31, 2016
Apr 29, 2016: Benitec Biopharma: Quarterly Cash Flow–Appendix 4C

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Benitec Biopharma Limited - Key Facts
Benitec Biopharma Limited - Key Employees
Benitec Biopharma Limited - Key Employee Biographies
Benitec Biopharma Limited - Major Products and Services
Benitec Biopharma Limited - Pharmaceutical Pipeline Products Data
Benitec Biopharma Limited, Pipeline Products by Therapy Area
Benitec Biopharma Limited, Pipeline Products by Development Phase
Benitec Biopharma Limited - History
Benitec Biopharma Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Benitec Biopharma Limited - Business Description
Benitec Biopharma Limited - Corporate Strategy
Benitec Biopharma Limited - SWOT Analysis
SWOT Analysis - Overview
Benitec Biopharma Limited - Strengths
Strength - Licensing Partnerships
Strength - Proprietary Technology
Strength - Strong Patent Position
Benitec Biopharma Limited - Weaknesses
Weakness - History of Losses
Benitec Biopharma Limited - Opportunities
Opportunity - Market Potential: RNA interference
Opportunity - Growth Prospects: Oncology
Opportunity - Strategic Acquisition
Benitec Biopharma Limited - Threats
Threat - Industry Regulations
Threat - Highly Competitive Industry
Threat - Uncertain R&D Outcomes
Benitec Biopharma Limited - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Benitec Biopharma Limited, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 16, 2016: Benitec Announces Appointment Of New Director And Chair Of Audit Committee And Retirement Of Director, Mr Iain Ross
Aug 10, 2016: Benitec announces restructuring of Senior Executive team
Jun 16, 2016: Benite Biopharma: Federal R&D Tax Credit Received
May 24, 2016: Benitec Biopharma Interim Report for the Nine Months Ended March 31, 2016
Apr 29, 2016: Benitec Biopharma: Quarterly Cash Flow–Appendix 4C
Apr 06, 2016: CSHL Reports That the U.S. Patent Office Denies All 4 Petitions Filed by Benitec Biopharma against CSHL’s shRNA Patents
Feb 26, 2016: Benitec Biopharma : Interim Report for the Half Year Ended December 31, 2015
Dec 08, 2015: Greg West, Benitec's Chief Financial Officer and Company Secretary, Named Interim Chief Executive Officer
Oct 19, 2015: Benitec Forms Hepatology Clinical Advisory
Oct 19, 2015: Benitec Forms Hepatology Clinical Advisory Board
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Benitec Biopharma Limited, Key Facts
Benitec Biopharma Limited, Key Employees
Benitec Biopharma Limited, Key Employee Biographies
Benitec Biopharma Limited, Major Products and Services
Benitec Biopharma Limited, Number of Pipeline Products by Therapy Area
Benitec Biopharma Limited, Number of Pipeline Products by Development Stage
Benitec Biopharma Limited, Pipeline Products By Therapy Area and Development Phase
Benitec Biopharma Limited, History
Benitec Biopharma Limited, Other Locations
Benitec Biopharma Limited, Subsidiaries
Benitec Biopharma Limited, Key Competitors
Benitec Biopharma Limited, Ratios based on current share price
Benitec Biopharma Limited, Annual Ratios
Benitec Biopharma Limited, Interim Ratios
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Benitec Biopharma Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Benitec Biopharma Limited, Pipeline Products by Therapy Area
Benitec Biopharma Limited, Pipeline Products by Development Phase
Benitec Biopharma Limited, Performance Chart (2011 - 2015)
Benitec Biopharma Limited, Ratio Charts
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report